Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and Carboplatin in Esophageal Cancer
NCT00383266Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2006
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed in esophageal cancer, sponsored by Washington University School of Medicine. Primary endpoint: Overall Response Rate. Started Oct 2006; status: terminated.
02
Drugs
pemetrexed
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00383266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383266.